AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Healixa Inc

$0.03 +$0.02 (+200.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.03
Day Range
$0.03$0.04
Year Range
$0.01$0.07
Market Cap
23M
AVG Volume
58.14K
Trailing/Forward PE
-300/-
PEG ratio
-4.08
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0100K200K300K400K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q10
25 Q30
25 Q20
25 Q1388.98K
24 Q494.19K
24 Q391.82K
24 Q2388.98K
24 Q1127.91K
23 Q4207.62K
23 Q3180.97K
Net Income (USD)
-3M-2M-1M023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q1-303.04K
25 Q3-225.08K
25 Q2-230.7K
25 Q1-51.23K
24 Q4-352.33K
24 Q3-141.68K
24 Q2-51.23K
24 Q1-211.66K
23 Q4-2.44M
23 Q3-262.5K
Operating Income (USD)
-3M-2M-1M01M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q1-267.39K
25 Q3-159.4K
25 Q2-150.02K
25 Q126.76K
24 Q4-181.81K
24 Q3-141.68K
24 Q226.76K
24 Q1-178.4K
23 Q4-2.35M
23 Q3-164.16K
EBITDA (USD)
-3M-2M-1M01M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q1-267.39K
25 Q3-159.4K
25 Q2-150.02K
25 Q137.79K
24 Q4-181.81K
24 Q3-141.68K
24 Q229.52K
24 Q1-170.12K
23 Q4-2.34M
23 Q3-155.88K
Cash Flows (USD)
-600K-400K-200K023 Q123 Q223 Q323 Q424 Q124 Q224 Q425 Q125 Q226 Q1
EMOR Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q1-119.45K
25 Q2-8.82K
25 Q1-151.79K
24 Q4-16.51K
24 Q2-68.89K
24 Q1-82.9K
23 Q4-188.27K
23 Q3-90.76K
23 Q2-160.61K
23 Q1-439.73K
EPS (USD)
-0-0-0-0023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR EPS (USD) by quarter
PeriodEPS (USD)
26 Q10
25 Q30
25 Q20
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
23 Q4-0
23 Q3-0
Expenses (USD)
-1M01M2M3MSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q20
23 Q10
26 Q1267.4K
25 Q3159.4K
25 Q2150.02K
25 Q1241.68K
24 Q4287.27K
24 Q3153.26K
24 Q2241.68K
24 Q1187.06K
23 Q42.47M
23 Q3246.66K
Cash & Debt (USD)
02M4M6M8MCashShort Term Debt23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q167.64K
25 Q30
25 Q228.52K
25 Q185.52K
24 Q439.14K
24 Q326.99K
24 Q285.52K
24 Q164.41K
23 Q492.31K
23 Q332.07K
Debt ratios
-30-20-10023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Debt ratios by quarter
PeriodDebt ratios
26 Q1-12.25
25 Q3-14.76
25 Q2-15.3
25 Q1-25.39
24 Q4-14.02
24 Q3-2.67
24 Q2-2.46
24 Q1-2.17
23 Q4-1.03
23 Q3-1.55
Margins
-400%-200%0%200%22 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q1
EMOR Margins by quarter
PeriodMargins
25 Q169.01%
24 Q4111.97%
24 Q312.6%
24 Q269.01%
24 Q16.77%
23 Q455.25%
23 Q345.59%
23 Q258.64%
23 Q1-295.95%
22 Q4-4.01%
Return on Capital
0%10%20%30%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Return on Capital by quarter
PeriodReturn on Capital
26 Q13.07%
25 Q32.32%
25 Q22.43%
25 Q10.51%
24 Q43.91%
24 Q31.34%
24 Q20.51%
24 Q12.1%
23 Q424.48%
23 Q32.27%
Shares Outstanding
0200M400M600M800M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Shares Outstanding by quarter
PeriodShares Outstanding
26 Q1766.68M
25 Q3766.7M
25 Q2766.68M
25 Q1766.65M
24 Q4766.72M
24 Q3766.65M
24 Q2766.65M
24 Q1766.57M
23 Q4768.87M
23 Q3776.07M
Book Value Per Share (USD)
-0.01-0.01-0023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q1-0.01
25 Q3-0.01
25 Q2-0.01
25 Q1-0.01
24 Q4-0.01
24 Q3-0.01
24 Q2-0.01
24 Q1-0.01
23 Q4-0.01
23 Q3-0.01
Total Assets (USD)
0200K400K600K800K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q326 Q1
EMOR Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q1211.27K
25 Q370.19K
25 Q261.52K
25 Q1624.6K
24 Q4228.64K
24 Q3533.03K
24 Q2624.6K
24 Q1538.2K
23 Q4624.97K
23 Q3514.32K
Free Cash Flow Yield
-6%-4%-2%0%med -1.13%Jul 23Oct 23Feb 24May 24Aug 24Dec 24Mar 25
EMOR Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Mar 25-1.4%
Mar 25-1.4%
Mar 25-1.4%
Mar 25-1.87%
Feb 25-1.4%
Feb 25-1.66%
Feb 25-1.4%
Feb 25-1.25%
Jan 25-1.03%
Jan 25-1.08%
Jan 25-1.12%
Jan 25-0.94%
Jan 25-0.95%
Dec 24-1.14%
Dec 24-1.51%
Dec 24-1.19%
Dec 24-1.05%
Nov 24-1.14%
Nov 24-1.32%
Nov 24-1.21%
Nov 24-1.14%
Nov 24-0.97%
Oct 24-1.14%
Oct 24-1.15%
Oct 24-0.99%
Oct 24-1.08%
Sep 24-1.43%
Sep 24-1.27%
Sep 24-1.43%
Sep 24-1.52%
Aug 24-1.63%
Aug 24-2.6%
Aug 24-2.29%
Aug 24-2.28%
Aug 24-2.33%
Jul 24-2.29%
Jul 24-2.16%
Jul 24-2.29%
Jul 24-3.34%
Jun 24-4.36%
Jun 24-3.1%
Jun 24-2.11%
Jun 24-1.86%
May 24-1.75%
May 24-1.74%
May 24-1.74%
May 24-1.12%
May 24-1.37%
Apr 24-1.27%
Apr 24-0.94%
Apr 24-1.07%
Apr 24-1%
Mar 24-1.19%
Mar 24-1.29%
Mar 24-1.29%
Mar 24-1.11%
Mar 24-1.17%
Feb 24-0.99%
Feb 24-0.98%
Feb 24-1.03%
Feb 24-0.82%
Jan 24-0.64%
Jan 24-0.62%
Jan 24-0.62%
Jan 24-0.64%
Dec 23-0.64%
Dec 23-1.01%
Dec 23-0.9%
Dec 23-0.9%
Dec 23-1.14%
Nov 23-1.23%
Nov 23-0.93%
Nov 23-0.9%
Nov 23-1.02%
Oct 23-1.09%
Oct 23-0.9%
Oct 23-0.93%
Oct 23-0.87%
Sep 23-0.87%
Sep 23-1.02%
Sep 23-1.05%
Sep 23-1.1%
Sep 23-1.19%
Aug 23-1.37%
Aug 23-1.19%
Aug 23-1.27%
Aug 23-1.4%
Jul 23-1.1%
Jul 23-1.1%
Jul 23-1.02%
Jul 23-0.81%
Jun 23-0.88%
Jun 23-0.41%
Jun 23-0.41%
Jun 23-0.42%
Jun 23-0.35%
May 23-0.32%
May 23-0.34%
May 23-0.35%
May 23-0.37%
Price to Sales
0255075100125med 33.87Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EMOR Price to Sales by quarter
PeriodPrice to Sales
Sep 2647.6
Sep 2647.6
Sep 2647.6
Aug 2663.47
Aug 2663.47
Aug 2663.47
Aug 2663.47
Jul 2661.57
Jul 2655.69
Jul 2679.34
Jul 2679.08
Jul 2695.21
Jun 26100.35
Jun 2663.47
Jun 2663.47
Jun 2679.34
May 2679.34
May 2679.34
May 2679.34
May 2679.34
May 2669.98
Apr 2647.6
Apr 2639.67
Apr 2664.74
Apr 2663.47
Mar 2680
Mar 2653.33
Mar 2653.33
Mar 2653.33
Feb 2653.33
Feb 2680
Feb 2672
Feb 2620
Jan 2619
Jan 2613.33
Jan 2613.47
Jan 2613.33
Jan 2613.33
Dec 258.75
Dec 257.95
Dec 257.95
Dec 259.94
Nov 2510.34
Nov 257.95
Nov 2511.93
Nov 2511.93
Oct 258.75
Oct 2510.14
Oct 257.95
Oct 257.95
Oct 257.95
Sep 2510.91
Sep 2513.09
Sep 2515.27
Sep 2513.63
Aug 2510.91
Aug 2510.91
Aug 2510.91
Aug 257.85
Aug 2514.18
Jul 2516.36
Jul 2514.83
Jul 2510.91
Jul 2512.98
Jun 258.17
Jun 258.81
Jun 2512.68
Jun 258.15
May 2511.48
May 259.39
May 259.39
May 2512.02
May 259.39
Apr 259.49
Apr 2514.09
Apr 2523.97
Apr 2537.57
Mar 2533.87
Mar 2533.87
Mar 2533.87
Mar 2525.4
Feb 2533.87
Feb 2528.68
Feb 2533.87
Feb 2538.1
Jan 2546.31
Jan 2544.03
Jan 2542.33
Jan 2550.8
Jan 2549.87
Dec 2466.32
Dec 2449.96
Dec 2463.45
Dec 2471.85
Nov 2466.32
Nov 2457.12
Nov 2462.09
Nov 2466.32
Nov 2477.37
Oct 2466.15
Price to Book
02.557.51012.5med 7.42Apr 21Jun 21Aug 21Oct 21Dec 21Jan 22Mar 22
EMOR Price to Book by quarter
PeriodPrice to Book
Mar 229.92
Mar 229.8
Mar 229.69
Mar 2210.64
Feb 2210.4
Feb 225.86
Feb 225.86
Feb 225.74
Jan 226.82
Jan 227.89
Jan 228.02
Jan 227.77
Dec 218.13
Dec 218.31
Dec 217.48
Dec 219.03
Dec 218.61
Nov 218.91
Nov 219.5
Nov 2110.93
Nov 219.86
Oct 218.43
Oct 218.19
Oct 217.72
Oct 217.13
Oct 217.36
Sep 213.74
Sep 212.93
Sep 214.22
Sep 212.04
Aug 214.43
Aug 213
Aug 213.06
Aug 213.27
Jul 216.4
Jul 215.58
Jul 213.88
Jul 214.63
Jul 215.11
Jun 215.51
Jun 214.53
Jun 215.04
Jun 216.67
May 216.4
May 217.15
May 217.15
May 218.17
Apr 218.85
Apr 218.17
Apr 219.26
Apr 219.39
Apr 2110.96
Healixa Inc
EMOR
Stockpicker

Video analysis: EMOR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.